Physician profile
Sumith Aleti
NPI 1629292875
$30,832.29
in general payments reported to CMS, 2019-2025
30 companies · $5,226 in 2025
The $5,226 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,967 · 2020: $1,458 · 2021: $1,717 · 2022: $2,655 · 2023: $5,298 · 2024: $12K · 2025: $5,226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $6,819 · Consulting Fee: $2,800 · Education: $16.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,400.00 |
| Food and Beverage | $6,819.07 |
| Consulting Fee | $2,800.00 |
| Education | $16.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $14,230.05 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $2,586.87 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Abiomed | $2,421.83 | 2019-2025 | Impella |
| Shockwave Medical, INC | $2,238.09 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $1,403.64 | 2021-2025 | Indigo System, Penumbra System, Smart Coil |
| Cardiovascular Systems INC. | $1,380.91 | 2019-2023 | Diamondback Coronary |
| Abbott Laboratories | $1,304.59 | 2019-2025 | Diamondback Coronary, Xience Skypoint, Diamondback Peripheral |
| Medtronic Vascular, INC. | $972.67 | 2019-2020 | |
| Heartflow, INC. | $725.28 | 2025 | |
| Medtronic, INC. | $576.24 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Resolute Onyx |
| W. L. Gore & Associates, INC. | $540.55 | 2019-2025 | Gore Acuseal Vascular Graft, Gore Acuseal Cardiovascular Patch Vascular, Gore Viabahn Vbx Balloon Expandable Endo |
| Novartis Pharmaceuticals Corporation | $446.73 | 2019-2025 | |
| Amgen INC. | $399.15 | 2020-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $296.85 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $281.40 | 2020-2025 | Wavewriter Alpha Prime 16 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $213.80 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $182.69 | 2019-2023 | Xarelto |
| Kestra Medical Technology Services, INC. | $171.28 | 2024-2025 | Assure Wcd |
| Cordis US Corp. | $111.07 | 2023-2024 | Mynxgrip, Mynx Control |
| Astrazeneca Pharmaceuticals LP | $82.73 | 2019-2023 | Farxiga |
| Teleflex LLC | $50.69 | 2020-2021 | |
| Chiesi USA, INC. | $46.55 | 2024-2025 | Kengreal, Cleviprex |
| Pfizer INC. | $45.56 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $34.57 | 2025 | Onpattro |
| Astellas Pharma US INC | $21.10 | 2020 | |
| Livanova USA, INC. | $14.98 | 2021 | |
| Ekos Corporation | $14.28 | 2019 | |
| Terumo Medical Corporation | $14.01 | 2023 | Navicross |
| Bard Peripheral Vascular, INC. | $13.06 | 2023 | Rotarexs 6 F X 135 Cm |
| Cardinal Health 200 LLC | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumith Aleti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.